How do APR and PQR differ in terms of the number of batches to be assessed in the review period?

12.09.2022

Question of the Week

While all batches have to be checked for the specified issues in the EU GMP Guide for the PQR, 21 CFR 211.180(e) requires a representative number of batches for the APR. There is however also a requirement to ensure that changes or irregularities are taken into account.

[GMP Compliance Adviser, Chapter 1.J]

Would you like to discover more?

The GMP Compliance Adviser is the world's largest knowledge portal for quality management in the pharma business.

The demo access is non-binding and ends automatically.

Test it now for free

You may also be interested in the following articles:

09.01.2026

News

PIC/S: Jordan FDA Joins PIC/S

On 1 January 2026, the Jordan Food & Drug Administration (JFDA) became the 57^th PIC/S Participating Authority.

Swissmedic: Scientific GMDP Meetings

Swissmedic offers companies holding or seeking a Swissmedic manufacturing or distribution license the opportunity to discuss project-specific GMP and GDP topics in Scientific GMDP Meetings.

Purified Water – The new Chinese Pharmacopoeias and What Happens Next? NEU

A new Chinese Pharmacopoeia was published in 2025. This has some significant implications for the pharmaceutical water industry, which we will discuss in more detail in this article. Firstly, it is important to note that cold WFI systems are now permitted worldwide and can be used across the board.